Hims & Hers HealthMEX:HIMS +4.05%58 PB Ratio is 16.96 as of Jun. 27, 2026, which is 151% above its 10-year median of 6.76. GuruFocus rates MEX:HIMS with a GF Score™ of 58/100 and a GF Value™ of MXN674.51 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 922 Drug Manufacturers companies, Hims & Hers Health ranks worse than 96.1% on this metric.
The historical rank and industry rank for Hims & Hers Health's PB Ratio or its related term are showing as below:
MEX:HIMS'
s PB Ratio Range Over the Past 10 Years
Min: 2.17 Med: 6.76 Max: 28.01
Current: 17.55
During the past 7 years, Hims & Hers Health's highest PB Ratio was 28.01. The lowest was 2.17. And the median was 6.76.
MEX:HIMS's PB Ratio is ranked worse than 96.1% of 922
companies
in the Drug Manufacturers industry
Industry Median: 1.825
vs MEX:HIMS: 17.55
During the past 12 months, Hims & Hers Health's average Book Value Per Share Growth Rate was -21.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 16.70% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Hims & Hers Health was 16.70% per year. The lowest was 9.70% per year. And the median was 13.20% per year.
Back to Basics: PB Ratio
Hims & Hers Health (MEX:HIMS) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Hims & Hers Health PB Ratio Related Terms
Hims & Hers Health PB Ratio Historical Data
* Premium members only.
The historical data trend for Hims & Hers Health's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Hims & Hers Health's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hims & Hers Health PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hims & Hers Health's PB Ratio distribution charts can be found below:
* The bar in red indicates where Hims & Hers Health's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Hims & Hers Health (MEX:HIMS) has a PB Ratio of 16.96 as of Jun. 27, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Hims & Hers Health and its competitors. This is 151% above median its historical median of 6.76. Over the past decade, Hims & Hers Health's PB Ratio has ranged from 2.17 to 28.01. According to the industry distribution chart, Hims & Hers Health ranks #886 out of 922 companies in the Drug Manufacturers industry, placing it in the top 96.1%.
Is Hims & Hers Health's PB Ratio too high?
Hims & Hers Health's current PB Ratio of 16.96 is 151% above median its 10-year median of 6.76. Over the past 10 years, this metric has ranged from a low of 2.17 to a high of 28.01. The Drug Manufacturers industry median PB Ratio is 1.83. Hims & Hers Health's value of 16.96 is 829.3% above this industry median. Based on the distribution chart, Hims & Hers Health ranks #886 out of 922 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Hims & Hers Health has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hims & Hers Health's PB Ratio compare to LNTH and LQDA?
According to the Drug Manufacturers industry distribution chart, Hims & Hers Health ranks #886 out of 922 companies for PB Ratio. This places Hims & Hers Health in the lower half of its industry. The industry median PB Ratio is 1.83. Hims & Hers Health's value of 16.96 is 829.3% above this benchmark. Historically, Hims & Hers Health's own PB Ratio has ranged from 2.17 to 28.01 over the past decade. While the company's 10-year median is 6.76 vs. the industry median of 1.83, Hims & Hers Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.83, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hims & Hers Health's current PB Ratio of 16.96 is 829.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Hims & Hers Health and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hims & Hers Health's current PB Ratio is 16.96, which is 151% above median its own 10-year median of 6.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hims & Hers Health stock overvalued right now?
Based on GuruFocus' analysis, Hims & Hers Health (MEX:HIMS) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN674.51, compared to a current price of MXN591.55 — trading 12.3% below its estimated fair value. The current PB Ratio is 16.96, which is 151% above median its 10-year median of 6.76 and 829.3% above the Drug Manufacturers industry median of 1.83. Hims & Hers Health's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Hims & Hers Health (MEX:HIMS), the current PB Ratio is 16.96 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hims & Hers Health (MEX:HIMS) Overvalued in 2026?
Based on GuruFocus' analysis, Hims & Hers Health stock appears to be undervalued.
The current stock price of MXN591.55 is trading 12.3% below its estimated GF Value™ of MXN674.51.
GuruFocus considers Hims & Hers Health to be Modestly Undervalued.
Key valuation signals for MEX:HIMS:
PB Ratio: 16.96 (151% above median its 10-year median of 6.76)
GF Value™: MXN674.51 vs. price of MXN591.55 (12.3% below fair value)
Industry Position: 829.3% above the Drug Manufacturers median (#886 of 922)
No single metric tells the full story. See the MEX:HIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
58GF Score
Get the complete analysis for MEX:HIMS
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:HIMS has been successfully added to your 
